Serum IL-1β as a Novel Predictor of No-Reflow in STEMI Patients Undergoing Primary PCI
Elevated serum IL-1β independently predicts no-reflow in STEMI patients, and its integration into the baseline model significantly enhances diagnostic performance, suggesting IL-1β as a potential therapeutic target.
Authors
- Shengfang Wang
- Hao Wang (ORCID: https://orcid.org/0000-0003-4493-3147)
- Chuanyu Gao (ORCID: https://orcid.org/0000-0002-7319-055X)
- Yanqing Huang (ORCID: https://orcid.org/0000-0003-1490-6383)
- Jialu Zhu (ORCID: https://orcid.org/0000-0002-9435-0460)
- Qianqian Cheng (ORCID: https://orcid.org/0000-0002-3935-5023)
Institutions
- Central South University (CN)
- Department of Embryology (US)
- Henan Provincial People's Hospital (CN)
- Zhengzhou Central Hospital (CN)
- Zhengzhou People's Hospital (CN)
- Henan Provincial Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/jir.s545890
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00